lead position
Sponsored content
Sponsored by
GlobalBlock
Features list
-
The in-house IP lawyer is often given responsibility for social media policy, even though many of the issues are nothing to do with IP infringement. Carmen Glatt and Kim Scallan give some advice on coping with the role
-
This year $50 billion worth of drugs come off patent. The pharma industry’s response will be to focus on personalised medicine and biologics. Eileen McDermott explains how this will shift IP strategy towards trade secrets, data and patenting processes
-
As the UK announces the details of its Patent Box, local lawyers from six jurisdictions in Europe explain how their tax incentives work and their relative successes
-
Benjamin Bai explains why a US decision that expands the jurisdiction of the ITC in trade secrets cases may be flawed, and contrasts it with the limited approach of the Supreme People’s Court in China
-
-
The trend: Dozens of interrelated cases between smartphone companies
The impact: Strategic points and important case law for all patent owners
Local Insights